MedTrace Logo

The Safety and Efficacy of Probiotic for Improving Intestinal and Immune Function

NCT06779994 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2025-08-29

No results posted yet for this study

Summary

To evaluate the safety and efficacy of Streptococcus salivarius subsp. thermophilus ST36 in healthy adults on immune function and intestinal health.

Conditions

  • Adults Aged 18-45 Years

Interventions

DIETARY_SUPPLEMENT

Probiotic

The experimental phase of this study will last 8 weeks and each subject will have three visits (day 0, week 4 and week 8).

DIETARY_SUPPLEMENT

Placebo

The experimental phase of this study will last 8 weeks and each subject will have three visits (day 0, week 4 and week 8).

Sponsors & Collaborators

  • Wecare Probiotics Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-10
Primary Completion
2025-05-06
Completion
2025-08-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06779994 on ClinicalTrials.gov